Bausch Health Companies Inc.
Stock Details
Is it expensive?
Trailing P/E Ratio
13.62
Forward P/E Ratio
1.42
PEG Ratio
-0.06
6.71
Price-to-Sales (TTM)
0.21
5.63
-1.50
Market Cap
2.12B
22.82B
Is it profitable?
Net Profit Margin (TTM)
1.53%
Gross Profit Margin
71.46%
Diluted EPS (TTM)
0.42
436.36%
10.27B
Is it growing?
9.30%
0.00%
Is it risky?
0.40
5.59K
1.47
21.08B
Who owns it?
65.67%
10.95%
2.00%
370.53M
222.97M
Does it pay?
70.36%
0.00%
--
--
How much cash?
1.31B
1.40B
1.09B
3.53
- Price
- 5.69
- Percent Change
- -0.04 (0.61%)
- Previous Close
- 5.72
- Open
- 5.76
- Low
- 5.69
- High
- 5.84
52-Week Range Position (52WRP)
Below Average
Below Average
within its 1-year price range
$5.69
From 52W Low
+32.83%
From 52W High
-34.58%
Today
-0.61%
1Y Change
+25.77%
6M
$6.02
3M
$7.26
1M
$5.03
Today
$5.69
From 52W Low
+32.83%
From 52W High
-34.58%
Today
-0.61%
1Y Change
+25.77%
6M
$6.02
3M
$7.26
1M
$5.03
Today
$5.69
Below Average
within its 1-year price range
$5.69
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+13.0%
3M
-21.7%
6M
-5.6%
1Y
+25.8%
Rate of Change (ROC)
Decelerating
Price has reversed, now rising vs its usual downtrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Bausch Health Companies Inc.
- Founded
- Jan 1, 1959
- Founders
- Milan Panić
- CEO
- Thomas J. Appio
- Employees
- 20,700
- Fiscal Year End
- Dec 31, 2024
- Address
2150 St. Elzear Boulevard West
Laval
Quebec
H7L 4A8
Canada
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Pharmaceuticals
- Website
- www.bauschhealth.com
Indicators
Operating Cash Flow
1.40B
Net Income
157.00M
Real Earnings
8.92
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Indicators
Operating Cash Flow
1.40B
Net Income
157.00M
Real Earnings
8.92
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
13.62
Forward P/E Ratio
1.42
PEG Ratio
-0.06
6.71
Price-to-Sales (TTM)
0.21
5.63
-1.50
Market Cap
2.12B
22.82B
Is it profitable?
Net Profit Margin (TTM)
1.53%
Gross Profit Margin
71.46%
Diluted EPS (TTM)
0.42
436.36%
10.27B
Is it growing?
9.30%
0.00%
Is it risky?
0.40
5.59K
1.47
21.08B
Who owns it?
65.67%
10.95%
2.00%
370.53M
222.97M
Does it pay?
70.36%
0.00%
--
--
How much cash?
1.31B
1.40B
1.09B
3.53
- Price
- 5.69
- Percent Change
- -0.04 (0.61%)
- Previous Close
- 5.72
- Open
- 5.76
- Low
- 5.69
- High
- 5.84
52-Week Range Position (52WRP)
Below Average
Below Average
within its 1-year price range
$5.69
From 52W Low
+32.83%
From 52W High
-34.58%
Today
-0.61%
1Y Change
+25.77%
6M
$6.02
3M
$7.26
1M
$5.03
Today
$5.69
From 52W Low
+32.83%
From 52W High
-34.58%
Today
-0.61%
1Y Change
+25.77%
6M
$6.02
3M
$7.26
1M
$5.03
Today
$5.69
Below Average
within its 1-year price range
$5.69
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+13.0%
3M
-21.7%
6M
-5.6%
1Y
+25.8%
Rate of Change (ROC)
Decelerating
Price has reversed, now rising vs its usual downtrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Bausch Health Companies Inc.
- Founded
- Jan 1, 1959
- Founders
- Milan Panić
- CEO
- Thomas J. Appio
- Employees
- 20,700
- Fiscal Year End
- Dec 31, 2024
- Address
2150 St. Elzear Boulevard West
Laval
Quebec
H7L 4A8
Canada
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Pharmaceuticals
- Website
- www.bauschhealth.com